NAMSNewAmsterdam Pharma Company N.V.

$27.41

What is the market doing?

What the tape says about NAMS

NewAmsterdam Pharma Company N.V. is +19% over the past year while the S&P 500 is +23%: 3.2 points behind the market.

+19%

1-year return · S&P 500 +23%

vs 200-day average
−17%

vs 200-day average · a clear downtrend

RSI (14)
49

RSI (14) · neutral

Below its 52-week high
−34%

Below its 52-week high

2024-08-06$14.90 – $41.45 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$27.41
1 monthS&P 500 +3.7%
−10%
1 yearS&P 500 +23%
+19%
5 yearsS&P 500 +87%
+183%
vs 50-day average$29.91
−8.4%
52-week high
$41.45
52-week low
$23.95
Annualised volatility
63%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$19M
Calendar-year price return
YearReturn
2026 (year to date)−22%
2025+36%
2024+130%
2023+2.5%
2022+12%
Average return by calendar month, 2021–2026
MonthYearsPositiveAverage
Jan53 of 5+16%
Feb52 of 5+3.7%
Mar63 of 6−1.7%
Apr62 of 6−2.9%
May61 of 6−1.1%
Jun63 of 6−2.8%
Jul62 of 6−0.97%
Aug62 of 6−1.0%
Sep54 of 5+2.2%
Oct53 of 5+6.7%
Nov53 of 5+2.9%
Dec53 of 5+13%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.